STRATA Skin Sciences Announces New Recurring Revenue Direct Distribution Contract with JMEC Co., Ltd. in Japan
HORSHAM, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in […]
Vaxart Announces FDA Clearance of IND Application for Oral COVID-19 Vaccine and Provides Update on COVID-19 Program
Recruitment for Phase 1 clinical study expected to start this monthData from ongoing hamster challenge study expected in OctoberSOUTH SAN […]
OneWater Marine Inc. Announces Public Offering of Common Stock
BUFORD, Ga., Sept. 14, 2020 (GLOBE NEWSWIRE) — OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the “Company”) announced today that […]
LexinFintech Announces Business Updates, Senior Management Announces Management Share Purchase Plan
SHENZHEN, China, Sept. 14, 2020 (GLOBE NEWSWIRE) — LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading online […]
Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public Health
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil […]
InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia
First site initiated for enrollment in the NetherlandsRegulatory approval granted to start trial in GermanyAdditional sites to be added in […]
Cassava Sciences Announces Final Results of a Phase 2b Clinical Study of Sumifilam in Patients with Alzheimer’s Disease
Alzheimer’s Patients in Drug Groups Showed Statistically Significant Improvements in Biomarkers of Disease Compared to Placebo Group (P<0.05)Alzheimer’s Patients in […]
Consolidated Communications Announces Intention to Offer Senior Secured Notes
MATTOON, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) — Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (“Consolidated”) announced today that its wholly-owned […]
Evelo Biosciences Appoints Julie Carretero as Chief People Officer
CAMBRIDGE, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new […]
89bio Announces Positive Topline Results from its Phase 1b/2a Trial of BIO89-100 in NASH
All dose groups achieved statistically significant reductions in liver fat, with relative reductions of up to 60% versus baseline and […]
